Botulinum Toxin Treatment of Glabellar Lines: Efficacy and Safety Study I
NCT02677298
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
784
Enrollment
INDUSTRY
Sponsor class
Conditions
Glabellar Frown Lines
Interventions
DRUG:
Botulinum Toxin A
DRUG:
Placebo
DRUG:
Botulinum Toxin A
Sponsor
Croma-Pharma GmbH